Soutenir la recherche

Publications et ressources

Trier par :
Afficher :
1-9 sur 9

Ultra-deep sequencing improves the detection of drug resistance in cellular DNA from HIV-infected patients on ART with suppressed viraemia.

Christophe RODRIGUEZ, ML Nere, Vanessa DEMONTANT, I Charreau, Mélanie MERCIER-DARTY, H Delagreverie, M Salmona, N de Castro, ML Chaix, JM Molina, C Delaugerre,

J Antimicrob Chemother. 01/11/2018;73(11) : 3122-3128 10.1093/jac/dky315

Drug resistance among patients who acquired HIV infection in a preexposure prophylaxis trial.

C Delaugerre, Christophe RODRIGUEZ, C Capitant, ML Nere, Mélanie MERCIER-DARTY, D Carette, G Pialoux, L Cotte, I Charreau, JM Molina, and the IPERGAY study group.

AIDS 23/10/2018;32(16) : 2353-2361 10.1097/QAD.0000000000001960.

Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues

Stephane CHEVALIEZ, Christophe RODRIGUEZ, Lila POITEAU, Alexandre SOULIER, F Donati, Mélanie MERCIER-DARTY, C Pioche, V Leroy, V Brodard, F Zoulim, C Brouard, C Larsen, C Semaille, F Roudot-Thoraval, Jean-Michel PAWLOTSKY, Hepatology Reference Centers Laboratories Network for Chronic Hepatitis B Surveillance

J Viral Hepat 19/10/2018;- : - 10.1111/jvh.13025

Genotypic and phenotypic characteristics of Escherichia coli involved in transfusion-transmitted bacterial infections: implications for preventive strategies.

M Desroches, O Clermont, B Lafeuillade, Christophe RODRIGUEZ, Mélanie MERCIER-DARTY, G Royer, O Bouvet, N Ounnoughene, F Noizat-Pirenne, E Denamur, JW Decousser,

Transfusion 01/08/2018;58(8) : 1940-1950 10.1111/trf.14812.

Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.

Mélanie MERCIER-DARTY, D Boutolleau, R Lepeule, Christophe RODRIGUEZ, S Burrel,

Antiviral Res. 01/03/2018;151 : 20-23 10.1016/j.antiviral.2018.01.008. 12/01/2018

The Odyssey of the Ancestral Escherich Strain through Culture Collections: an Example of Allopatric Diversification

M Desroches, G Royer, D Roche, Mélanie MERCIER-DARTY, D Vallenet, C Medigue, JP Bastard, Christophe RODRIGUEZ, O Clermont, E Denamur, JW Decousser,

mSphere 31/01/2018;3(1) : pii: e00553-17 10.1128/mSphere.00553-17.

Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).

C Soulie, L Assoumou, Mélanie MERCIER-DARTY, Christophe RODRIGUEZ, F Donati, S Sayon, G Peytavin, MA Valantin, F Caby, L Schneider, A Canestri, D Costagliola, C Katlama, V Calvez, AG Marcelin,

J Antimicrob Chemother. 01/12/2015;70(12) : 3339-3344 10.1093/jac/dkv280 22/09/2015

Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing.

E Todesco, Christophe RODRIGUEZ, L Morand-Joubert, Mélanie MERCIER-DARTY, N Desire, M Wirden, PM Girard, C Katlama, V Calvez, AG Marcelin,

J antimicrob Chemother. 01/05/2015;70(5) : 1503-1506 10.1093/jac/dku557. 21/01/2015

Afficher :
1-9 sur 9